Cargando…
Ten years of progress in radiation oncology
Over the last decade, BMC Cancer has continuously published important research from the field of radiation oncology. Major developments in this field include the introduction of new imaging modalities into radiotherapy planning, the availability of hardware and software for more precise delivery of...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259125/ https://www.ncbi.nlm.nih.gov/pubmed/22128868 http://dx.doi.org/10.1186/1471-2407-11-503 |
_version_ | 1782221349326946304 |
---|---|
author | Vordermark, Dirk |
author_facet | Vordermark, Dirk |
author_sort | Vordermark, Dirk |
collection | PubMed |
description | Over the last decade, BMC Cancer has continuously published important research from the field of radiation oncology. Major developments in this field include the introduction of new imaging modalities into radiotherapy planning, the availability of hardware and software for more precise delivery of radiation dose, the individualization of radiotherapy concepts, for example, based on microarray data, and the combination of radiotherapy with molecular targeting approaches to overcome the radioresistance of tumor cells. |
format | Online Article Text |
id | pubmed-3259125 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-32591252012-01-17 Ten years of progress in radiation oncology Vordermark, Dirk BMC Cancer Commentary Over the last decade, BMC Cancer has continuously published important research from the field of radiation oncology. Major developments in this field include the introduction of new imaging modalities into radiotherapy planning, the availability of hardware and software for more precise delivery of radiation dose, the individualization of radiotherapy concepts, for example, based on microarray data, and the combination of radiotherapy with molecular targeting approaches to overcome the radioresistance of tumor cells. BioMed Central 2011-11-30 /pmc/articles/PMC3259125/ /pubmed/22128868 http://dx.doi.org/10.1186/1471-2407-11-503 Text en Copyright ©2011 Vordermark; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Commentary Vordermark, Dirk Ten years of progress in radiation oncology |
title | Ten years of progress in radiation oncology |
title_full | Ten years of progress in radiation oncology |
title_fullStr | Ten years of progress in radiation oncology |
title_full_unstemmed | Ten years of progress in radiation oncology |
title_short | Ten years of progress in radiation oncology |
title_sort | ten years of progress in radiation oncology |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259125/ https://www.ncbi.nlm.nih.gov/pubmed/22128868 http://dx.doi.org/10.1186/1471-2407-11-503 |
work_keys_str_mv | AT vordermarkdirk tenyearsofprogressinradiationoncology |